Swiss scientists have found that a substance derived from pomegranate has potential anti-aging properties . The new discoveries add more weight to the already established reputation of the fruit as a superfood and stimulate the ambitions of a local biotechnology company to develop a product based on this.
Researchers from the Ecole Polytechnique Federale de Lausanne (EPFL) announced that the results of the use of urolithin A in clinical trials show that the substance has the potential to slow aging by up to 42% .
Urolithin A is produced in the body when compounds known as elagitanins , which are found in pomegranates, are broken down by bacteria in the gut .
The EPFL team is working with biotechnology company Amazentis to develop a nutritional supplement that can increase muscle strength and endurance during aging. Results from the first clinical trials of the product are expected next year.
"We believe that our research reveals the health benefits of the substance urolithin A and makes a claim for overcoming muscle aging. It's a completely natural substance and its effect is powerful and measurable, "said Patrick Abeisher, president of EPFL and co-founder of Amazentis , quoted by Reuters .
Some time ago, scientists from the University of California proved that some components in pomegranate juice can stop the development of cancer cells in prostate cancer . Israeli researchers have found that the juice of this fruit can destroy cancer cells in breast cancer .
A specific polyphenol in pomegranate, called punicalagin , is thought to be a source of anti-inflammatory properties. Another study showed that pomegranate juice reduced the levels of amyloid plaques that accumulate between nerve cells in the brain and are an integral part of the clinical picture of Alzheimer's disease .